Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

The interleukin-10 promoter polymorphism rs1800872 (-592C>A), contributes to cancer susceptibility: meta-analysis of 16,785 cases and 19,713 controls.

Ding Q, Shi Y, Fan B, Fan Z, Ding L, Li F, Tu W, Jin X, Wang J.

PLoS One. 2013;8(2):e57246. doi: 10.1371/journal.pone.0057246. Epub 2013 Feb 27.

2.

The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.

Wang J, Ding Q, Shi Y, Cao Q, Qin C, Zhu J, Chen J, Yin C.

Mutagenesis. 2012 May;27(3):305-12. doi: 10.1093/mutage/ger078. Epub 2011 Nov 4.

PMID:
22058059
3.

Interleukin-10-819C>T polymorphism contributed to cancer risk: evidence from 29 studies.

Ding Q, Fan B, Fan Z, Ding L, Li F, Tu W, Jin X, Shi Y, Wang J.

Cytokine. 2013 Jan;61(1):139-45. doi: 10.1016/j.cyto.2012.09.008. Epub 2012 Oct 6.

PMID:
23046616
4.

Interleukin 10 polymorphisms and cervical cancer risk: a meta-analysis.

Ni J, Ye Y, Teng F, Wu Q.

Int J Gynecol Cancer. 2013 Jan;23(1):126-33. doi: 10.1097/IGC.0b013e318274b1a2.

PMID:
23095823
5.

Association of IL-10-1082 promoter polymorphism with susceptibility to gastric cancer: evidence from 22 case-control studies.

Pan F, Tian J, Pan YY, Zhang Y.

Mol Biol Rep. 2012 Jun;39(6):7143-54. doi: 10.1007/s11033-012-1546-7. Epub 2012 Feb 5.

PMID:
22311038
6.

The Cox-2 -1195 G > A polymorphism and cancer risk: a meta-analysis of 25 case-control studies.

Tang Z, Nie ZL, Pan Y, Zhang L, Gao L, Zhang Q, Qu L, He B, Song G, Zhang Y, Shukui Wang.

Mutagenesis. 2011 Nov;26(6):729-34. doi: 10.1093/mutage/ger040. Epub 2011 Jul 6.

PMID:
21734230
7.

The associations between two polymorphisms in the interleukin-10 gene promoter and breast cancer risk.

Yu KD, Chen AX, Yang C, Fan L, Huang AJ, Shao ZM.

Breast Cancer Res Treat. 2012 Jan;131(1):27-31. doi: 10.1007/s10549-010-1133-3. Epub 2010 Aug 25.

PMID:
20737205
8.

Interleukin-10 gene -592C>A polymorphism and susceptibility to gastric cancer.

Qi M, Liu DM, Pan LL, Lin YX.

Genet Mol Res. 2014 Oct 31;13(4):8954-61. doi: 10.4238/2014.October.31.10.

9.

Association of interleukin-10 (IL10) promoter genotypes with nasopharyngeal carcinoma risk in Taiwan.

Tsai CW, Tsai MH, Shih LC, Chang WS, Lin CC, Bau DT.

Anticancer Res. 2013 Aug;33(8):3391-6.

PMID:
23898109
10.

The association between three promoter polymorphisms of IL-10 and inflammatory bowel diseases (IBD): a meta-analysis.

Zou L, Wang L, Gong X, Zhao H, Jiang A, Zheng S.

Autoimmunity. 2014 Feb;47(1):27-39. doi: 10.3109/08916934.2013.843672. Epub 2013 Oct 16.

PMID:
24128120
11.

Interleukin-10 promoter 1082/-819/-592 polymorphisms are associated with asthma susceptibility in Asians and atopic asthma: a meta-analysis.

Zheng XY, Guan WJ, Mao C, Chen HF, Ding H, Zheng JP, Hu TT, Luo MH, Huang YH, Chen Q.

Lung. 2014 Feb;192(1):65-73. doi: 10.1007/s00408-013-9519-8. Epub 2013 Oct 27. Review.

PMID:
24162871
12.

-765G>C and 8473T>C polymorphisms of COX-2 and cancer risk: a meta-analysis based on 33 case-control studies.

Zhu W, Wei BB, Shan X, Liu P.

Mol Biol Rep. 2010 Jan;37(1):277-88. doi: 10.1007/s11033-009-9685-1. Epub 2009 Aug 9.

PMID:
19669667
13.

Interleukin 1 beta (IL1B) promoter polymorphism and cancer risk: evidence from 47 published studies.

He B, Zhang Y, Pan Y, Xu Y, Gu L, Chen L, Wang S.

Mutagenesis. 2011 Sep;26(5):637-42. doi: 10.1093/mutage/ger025. Epub 2011 Jun 7.

PMID:
21653279
14.

A meta-analysis of interleukin-10 -592 promoter polymorphism associated with gastric cancer risk.

Xue H, Wang YC, Lin B, An J, Chen L, Chen J, Fang JY.

PLoS One. 2012;7(7):e39868. doi: 10.1371/journal.pone.0039868. Epub 2012 Jul 31.

15.

An association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer in non-smokers: a meta-analysis.

Ji C, Liu Z, Chen H, Guo H, Liu C.

BMC Cancer. 2012 Aug 2;12:335. doi: 10.1186/1471-2407-12-335.

16.

Association between the OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and lung cancer risk: a meta-analysis.

Wei W, He XF, Qin JB, Su J, Li SX, Liu Y, Zhang Y, Wang W.

Mol Biol Rep. 2012 Dec;39(12):11249-62. doi: 10.1007/s11033-012-2035-8. Epub 2012 Oct 12.

PMID:
23065211
17.

The hOGG1 Ser326Cys polymorphism contributes to cancer susceptibility: evidence from 83 case-control studies.

Wang W, Wang M, Chen Y, Zhang Z, Wang S, Xu M, Wang B, Zhao Q, Zhang Z.

Mutagenesis. 2012 May;27(3):329-36. doi: 10.1093/mutage/ger083. Epub 2011 Nov 25.

PMID:
22121210
18.

P21 codon 31 polymorphism associated with cancer among white people: evidence from a meta-analysis involving 78,074 subjects.

Liu F, Li B, Wei Y, Chen X, Ma Y, Yan L, Wen T.

Mutagenesis. 2011 Jul;26(4):513-21. doi: 10.1093/mutage/ger010. Epub 2011 Mar 17.

PMID:
21415438
19.

Meta-analysis of epidemiological studies of association of two polymorphisms in the interleukin-10 gene promoter and colorectal cancer risk.

Zhang YM, Zhou XC, Xu Z, Tang CJ.

Genet Mol Res. 2012 Sep 25;11(3):3389-97. doi: 10.4238/2012.September.25.7.

20.

The TERT MNS16A polymorphism contributes to cancer susceptibility: meta-analysis of the current studies.

Chen P, Zou P, Yan Q, Xu H, Zhao P, Gu A.

Gene. 2013 May 1;519(2):266-70. doi: 10.1016/j.gene.2013.02.018. Epub 2013 Feb 24.

PMID:
23462332

Supplemental Content

Support Center